Peptides, complex molecules made of amino acids, play a critical role in regulating neurotransmitters such as serotonin and dopamine. This regulation is fundamental to maintaining healthy psychological well-being. Recent research suggests that the problem of depression may not be caused by a "chemical imbalance" but rather by a malfunction in the regulation and signaling of these chemicals. The development of synthetic peptides such as Selank has opened new opportunities for the treatment of depression and anxiety and Renew Life RX is here to help. Selank is considered to be an "anti-anxiety" peptide and has been shown to improve cognitive functions such as memory, learning, depression, and fatigue.
Hormone Therapy
Hormones are powerful chemical messengers that keep your body functioning properly, controlling many of the functions of your organs and tissues. They are released by specific glands such as the adrenal, pituitary, thyroid, and ovaries/testes as needed. When these hormones become imbalanced, it can lead to changes in mood, such as feeling tired, irritable, or out of sorts. Imbalanced hormones can also affect other aspects of your health such as cortisol, testosterone, thyroid hormone, estrogen, and progesterone. Hormones work closely with brain chemicals called neurotransmitters, such as dopamine, serotonin, testosterone, and GABA, which can also affect mood, focus and concentration, libido, fatigue, and panic attacks. When you notice these changes, it is important to investigate the potential cause and find a way to balance the hormones.
How Selank Works
Selank has been found to modulate the expression of Interleukin-6 (IL-6), which plays a role in immune system and inflammation response. By affecting the balance of T helper cell cytokines, Selank can also alter the immune system's response to stress and other stimuli. Selank has been shown to influence the concentration of monoamine neurotransmitters such as serotonin and dopamine, which can lead to changes in mood and anxiety levels. It has been found to induce metabolism of serotonin which can improve mood and cognitive function. The peptide also increases the expression of brain-derived neurotrophic factor (BDNF), a protein that helps to support the growth, survival and function of neurons in the brain and can enhance learning, memory and mood. All these mechanisms working together make Selank a potential therapeutic agent in treating anxiety and depression.
Selnak and Serotonin
Did you know that the hormone serotonin plays a crucial role in our psychological well-being? As a neurotransmitter and hormone, serotonin helps to transmit messages throughout the body and regulate mood, appetite, sleep, memory, learning, and social behavior. Although the majority of serotonin is found in the gastrointestinal tract, the small amount produced in the brain plays a major role in mental health conditions such as depression and anxiety. A deficiency in serotonin can lead to psychological problems. Selank has been found to increase serotonin levels by correcting any decrease in serotonin metabolism. According to a study*, Selank demonstrated complex effects on nerve cells, with an anti-anxiety and ant-depressive effect.
What We Know About Selak From Clinical Trials
Within clinical trials, the peptide Selank has been shown to provide a sustained nootropic and anti-anxiety effect, which may assist in the treatment of generalized anxiety disorder (GAD). Selank has an advantage over traditional anxiety treatments, such as prescription medications for its ease of use, safety, and accessibility. Studies suggest that Selank may potentially help curb anxiety and offer many other benefits. Research into peptides is relatively new, and we are constantly discovering more about the untapped potential of peptides.
Selank Therapy for Anxiety
Selank is known for its ability to reduce anxiety. A study comparing Selank to an anti-anxiety drug showed that Selank had a similar anti-anxiety effect on patients with generalized anxiety disorder** The specific way in which Selank works is not fully understood, but it is believed to alter the levels of certain brain chemicals such as serotonin and dopamine which are involved in mood regulation. The effects of Selank can be felt within hours, but the full effects may take several days or weeks to show. The treatment duration with Selank varies based on the condition and the individual's response to the medication.
Selank Therapy for Depression
Depression is a leading cause of psychiatric disability in the United States, and it affects more than 6 percent of the population each year with lifetime prevalence exceeding 15 percent. Antidepressant medications are a commonly used treatment for depression. However, if these medications do not effectively reduce your symptoms. It is also common for people to experience unwanted side effects when taking antidepressants. These can include nausea, weight gain, or sleep issues, and may occur initially. For many individuals, these side effects improve or disappear after a few weeks of starting the medication. However, in some cases, the side effects of antidepressants may persist and not improve over time. Selnak has shown fewer adverse effects when used in studies compared to commonly prescribed medications to treat depression.
Book an initial consultation at 877-722-1663 to discuss your current condition, and answer any questions you may have. At Renew Life our approach is tailored to your specific needs. We will design a treatment plan and will have it delivered to your doorstep from our accredited pharmacy partners. We will closely monitor your progress through regular check-ins with our dedicated staff and expert doctors to ensure you achieve the maximum results.
* T. Kolomin, et al. A New Generation of Drugs: Synthetic Peptides Based on Natural Regulatory Peptides, Neuroscience and Medicine, Vol. 4 No. 4, 2013, pp. 223-252.**Zozulia, A A., et al. Efficacy and Possible Mechanisms of Action of a New Peptide Anxiolytic Selank in the Therapy of Generalized Anxiety Disorders and Neurasthenia. Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova, vol. 108, no. 4, 2008, pp. 38-48.
